Abstract | BACKGROUND: Papulosquamous eruptions are common in HIV-1-infected patients. Acquired ichthyosis may occur after profound T-cell depletion. Intravenous drug users infected with HIV-1 can be coinfected with human lymphotropic virus II (HTLV-II). OBJECTIVE: We examined the relation between acquired ichthyosis and concomitant infection with HIV-1 and HTLV-II in intravenous drug users. METHODS: We examined 184 male and female HIV-1-positive intravenous drug users for acquired ichthyosis. Enzyme-linked immunosorbent assay was used to screen these patients for antibody to HTLV-I/II. Western blot, viral isolation, and the polymerase chain reaction were used to confirm that serologic responses were from HTLV-II and not HTLV-I. RESULTS: Acquired ichthyosis occurred in 6.3% of white, 16.4% of Hispanic, and 21.7% of black patients. It occurred only after profound helper T-cell depletion, in association with increasing age, and with concomitant infection with HTLV-II (22.2% vs. 6.8% in HIV-1 singly infected patients [p < 0.038]). CONCLUSION: Acquired ichthyosis may be a marker of concomitant infection with HIV-1 and HTLV-II in intravenous drug users and occurs after profound helper T-cell depletion.
|
Authors | M H Kaplan, N S Sadick, N S McNutt, M Talmor, M Coronesi, W W Hall |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 29
Issue 5 Pt 1
Pg. 701-8
(Nov 1993)
ISSN: 0190-9622 [Print] United States |
PMID | 8227542
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Acquired Immunodeficiency Syndrome
(complications, diagnosis, immunology, microbiology)
- Adult
- DNA, Viral
(analysis)
- Female
- HIV-1
(isolation & purification)
- HTLV-II Infections
(complications, diagnosis, immunology, microbiology)
- Human T-lymphotropic virus 1
(isolation & purification)
- Human T-lymphotropic virus 2
(isolation & purification)
- Humans
- Ichthyosis
(complications, diagnosis, immunology, microbiology)
- Male
- Polymerase Chain Reaction
- Substance Abuse, Intravenous
- T-Lymphocytes, Helper-Inducer
(immunology)
|